https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-12-11 12:30:192016-11-28 12:32:01Astex Wins Company Newsflow of the Year Award
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-12-01 12:32:122016-11-28 12:32:46SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-11-23 12:33:002016-11-28 12:33:21Astex Granted Orphan Drug Status for AT9283 in AML in USA and Europe
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-11-12 12:33:302016-11-28 12:33:49Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKline
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-11-09 11:34:452016-11-28 12:35:06Astex to disclose the structure of its HSP90 inhibitor, AT13387, at the AACR-NCI-EORTC Annual Meeting 2009
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-11-03 12:35:172016-11-28 12:35:51Astex Announces a CRADA with the National Cancer Institute for its HSP90 inhibitor AT13387
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-10-26 11:36:332016-11-28 12:36:57SuperGen and GSK to Collaborate on the Discovery and Development of Novel Epigenetic Therapeutics
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2009-09-21 12:37:072016-11-28 12:37:35David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
